| PDIAX | VIVIX | PDIAX / VIVIX | |
| Total Expense Ratio | 1.14 | 0.03 | 3,800% |
| Annual Report Gross Expense Ratio | 1.37 | 0.03 | 4,567% |
| Fund Existence | 29 years | 28 years | - |
| Gain YTD | 12.359 | 14.468 | 85% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 173M | 245B | 0% |
| Annual Yield % from dividends | 1.63 | 1.87 | 87% |
| Returns for 1 year | 14.77 | 25.33 | 58% |
| Returns for 3 years | 39.41 | 57.96 | 68% |
| Returns for 5 years | 31.68 | 60.17 | 53% |
| Returns for 10 years | 59.36 | 166.35 | 36% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MRFGX | 22.88 | N/A | N/A |
| BlackRock Capital Appreciation R | |||
| MDVNX | 9.16 | N/A | N/A |
| MassMutual Diversified Value R3 | |||
| VSIIX | 57.38 | N/A | N/A |
| Vanguard Small Cap Value Index I | |||
| TCMPX | 19.76 | N/A | N/A |
| AMG TimesSquare International SmallCap N | |||
| AVEEX | 17.87 | -0.93 | -4.95% |
| Avantis® Emerging Markets Equity Instl | |||